Osimertinib

Reactions Weekly 2026

View at publisher
DOI: 10.1007/s40278-026-92954-x
Cited by: 0
References: 1

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Pharmacovigilance and Adverse Drug Reactions HER2/EGFR in Cancer Research

Publication details

Journal / source
Reactions Weekly
Volume
2100
Issue
1
Pages
98–98
Publication date
7 March 2026
Language
EN